Announced
Financials
Tags
Pending
Private
Acquisition
Majority
Italy
Single Bidder
medical devices
Medical Supplies
Friendly
Domestic
Synopsis
PharmaNutra, a pharmaceutical company, agreed to acquire Akern, a firm engaged in the production and commercialization of medical devices and software for the monitoring of the body composition through bio-impedance techniques, from Red Lions, Jacopo Talluri and Liside for $15m. “The acquisition of Akern represents a turning point for both the companies and a key milestone in the implementation of PharmaNutra’s growth strategy. Akern is a cash generating company with a growing business which will allow the realization of important strategic synergies, starting from 2023, with a boost and diversification of the business lines. Pharmanutra will heavily strengthen its know how benefiting from more than 40 years’ experience of a leading Italian company in the bio-impedance analysis, and it will support Akern in consolidating its presence in the Italian and International markets through our capillary network of distributors," Andrea Lacorte, Pharmanutra Chairman.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.